BLESSEN GEORGE: Open Payments
NPI 1871347567 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $150 |
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 2 | $97 |
| Dexcom, Inc. | 3 | $65 |
| Intra-Sana Laboratories | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| PFIZER INC. | 1 | $15 |
Products named: RECORLEV, Wegovy, Dexcom G6 Transmitter, GLYCATE, Kerendia, MOUNJARO, OTEZLA, PYRUKYND.
Industry payments across NY — which companies pay providers there.
